BioSpace News Archive

Added to previously granted U.S. patent protecting the use of COM902 for T cell activation in cancer patients

Conference Call to be Held on November 12, 2019

International Medical Solutions (“IMS”) and Eastern Health have signed an agreement to optimize peer learning for Medical Imaging, along with an option to deliver future peer learning programs to all of Newfoundland and Labrador, Canada.

Simulations Plus, Inc., announced that it will report its fourth quarter and full year financial results for fiscal year 2019, ended August 31, 2019, after the close of the financial markets on Wednesday, November 13, 2019.

Discovery marks the first time a new subtype of HIV-1 has been identified since 2000

The company will use the Series A funds to develop the technology, conduct clinical studies, and pursue FDA approval.

Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), today announced that it will host a conference call at 1:00 PM Eastern Time on Wednesday, November 13, 2019 to discuss the Company’s financial results for the second quarter ended September 30, 2019,

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that clinical data on its investigational BTK inhibitor zanubrutinib will be presented in two oral presentations and two posters at the 61st American Society of Hematology (ASH) Annual Meeting, taking place December 7 – 10, 2019 in Orlando, FL.

26 relapsed/refractory EBV+ PTLD patients were treated in a multicenter tab-cel® EAP study including a subgroup of 22 patients who would have likely met eligibility criteria for Atara’s ongoing tab‑cel® Phase 3 studies

Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced the upcoming presentation of registrational data from multiple programs at the 61st American Society of Hematology (ASH) Annual Meeting in Orlando, FL